01 1Alivus Life Sciences
01 1GABAPENTIN ENACARBIL
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2018-11-21
Pay. Date : 2018-11-02
DMF Number : 33296
Submission : 2018-11-02
Status : Active
Type : II
20
Alivus Life Sciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is GABAPENTIN ENACARBIL, with a corresponding US DMF Number 33296.
Remarkably, this DMF maintains an Active status since its submission on November 02, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 21, 2018, and payment made on November 02, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II
